Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728260 · ClinicalTrials.gov registry record
36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 1,421
- Enrollment target
NCT00728260: Completed study, sponsored by Sanofi Pasteur, a Sanofi Company.
NCT00728260 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 1,421 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00728260 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 1,421 participants
- Enrollment target
Study Summary
To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
Primary Outcome
Incidence rates for each diagnosis were calculated as the number of events divided by person-time and expressed as events per 1,000 person-months in each comparison window. Clinical setting is given in parenthesis as (H) for hospital.
Interventions
- BIOLOGICAL None administered in this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,421 participants |
| Start Date | 2005-07 |
| Est. Completion | 2013-05 |
What the finished NCT00728260 record still lists
NCT00728260 is an observational study that tracks outcomes without assigning an intervention. Its 1,421 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which None administered in this study is the first listed.
NCT00728260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00728260 about?
NCT00728260 is a clinical study titled "36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds". To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
What is the current status of trial NCT00728260?
This trial is currently completed. The enrollment target is 1,421 participants. The study started on 2005-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00728260?
The interventions under investigation include: None administered in this study (BIOLOGICAL).
Who is sponsoring clinical trial NCT00728260?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia